| EP4225366 - IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.07.2023 Database last updated on 10.03.2026 | |
| Former | The international publication has been made Status updated on 16.04.2022 | Most recent event Tooltip | 28.10.2025 | New entry: Renewal fee paid | Applicant(s) | For all designated states Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place New York, NY 10029 / US | For all designated states Universiteit Gent Sint-Pietersnieuwstraat 25 9000 Gent / BE | [2024/21] |
| Former [2023/33] | For all designated states Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place New York, NY 10029 / US | ||
| For all designated states Universiteit Gent Sint-Pietersnieuwstraat 25 9000 Gent / BE | Inventor(s) | 01 /
GARCIA-SASTRE, Adolfo New York, NY 10029 / US | 02 /
SCHOTSAERT, Michael New York, NY 10029 / US | 03 /
CHOI, Angela New York, NY 10029 / US | 04 /
DE GEEST, Bruno 9000 Gent / BE | 05 /
DE VRIEZE, Jana 9000 Gent / BE | [2023/33] | Representative(s) | Studio Torta S.p.A. Via Viotti, 9 10121 Torino / IT | [N/P] |
| Former [2023/33] | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | Application number, filing date | 21878555.8 | 07.10.2021 | [2023/33] | WO2021US54024 | Priority number, date | US202063089442P | 08.10.2020 Original published format: US 202063089442 P | [2023/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022076723 | Date: | 14.04.2022 | Language: | EN | [2022/15] | Type: | A1 Application with search report | No.: | EP4225366 | Date: | 16.08.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.04.2022 takes the place of the publication of the European patent application. | [2023/33] | Search report(s) | International search report - published on: | US | 14.04.2022 | (Supplementary) European search report - dispatched on: | EP | 04.10.2024 | Classification | IPC: | A61K39/39, A61K47/60, A61K31/4745, A61K31/80, C07D471/04, C07J9/00 | [2024/45] | CPC: |
A61K47/60 (EP);
C07D471/04 (EP,US);
A61K39/12 (EP);
A61K39/215 (US);
A61K39/39 (EP);
A61K47/554 (EP);
A61P31/14 (EP,US);
A61P31/16 (EP);
C07J43/003 (EP);
A61K2039/543 (EP);
A61K2039/555 (EP);
A61K2039/55505 (EP);
A61K2039/55511 (US);
A61K2039/57 (EP);
A61K2039/575 (EP,US);
A61K2039/70 (EP);
C12N2710/10343 (EP);
C12N2760/16134 (EP);
|
| Former IPC [2023/33] | A61K39/39, A61K47/60, A61K31/4745, A61K31/80 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/33] | Title | German: | IMDQ-PEG-CHOL-ADJUVANS UND VERWENDUNGEN DAVON | [2023/33] | English: | IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF | [2023/33] | French: | ADJUVANT IMDQ-PEG-CHOL ET UTILISATIONS ASSOCIÉES | [2023/33] | Entry into regional phase | 22.03.2023 | National basic fee paid | 22.03.2023 | Search fee paid | 22.03.2023 | Designation fee(s) paid | 22.03.2023 | Examination fee paid | Examination procedure | 22.03.2023 | Examination requested [2023/33] | 22.04.2025 | Date on which the examining division has become responsible | 09.05.2025 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 08.07.2025 | Amendment by applicant (claims and/or description) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 08.07.2025 | Request for further processing filed | 08.07.2025 | Full payment received (date of receipt of payment) Request granted | 16.07.2025 | Decision despatched | Fees paid | Renewal fee | 27.10.2023 | Renewal fee patent year 03 | 28.10.2024 | Renewal fee patent year 04 | 27.10.2025 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] JANA DE VRIEZE ET AL: "Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer-Lipid Amphiphile Conjugates of Small-Molecule TLR7/8 Agonists", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, VERLAG CHEMIE, HOBOKEN, USA, vol. 58, no. 43, 12 September 2019 (2019-09-12), pages 15390 - 15395, XP072102682, ISSN: 1433-7851, DOI: 10.1002/ANIE.201905687 [A] 1-15 * Scheme 2; page 15390, column right, paragraph last - page 15391, column left, paragraph 2 * * figures 3,4C1 * * figure 4 * DOI: http://dx.doi.org/10.1002/anie.201905687 | [A] HE ZHI-YAO ET AL: "Recent development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, vol. 469, no. 1, 25 April 2014 (2014-04-25), pages 168 - 178, XP029029889, ISSN: 0378-5173, DOI: 10.1016/J.IJPHARM.2014.04.056 [A] 1-15 * paragraph [0004]; figure 4 * DOI: http://dx.doi.org/10.1016/j.ijpharm.2014.04.056 | [T] JANGRA SONIA ET AL: "Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine**", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 60, no. 17, 11 March 2021 (2021-03-11), Hoboken, USA, pages 9467 - 9473, XP055943944, ISSN: 1433-7851, Retrieved from the Internet DOI: http://dx.doi.org/10.1002/anie.202015362 | International search | [A] WO2013166110 (UNIV YALE et al.) [A] 1-8, 12-20, 29-35, 58, 60- 63, 89-91; 93 * Sheet 4, Figure 4 * | [A] US8946421 (JOHNSON DAVID A et al.) [A] 1-8, 12-20, 29-35, 58, 60-63, 89-91; 93 * Col 3, In 45-61; Col 4. In 10-31 * | [A] US2018110874 (LI LIXIN et al.) [A] 1-8, 12-20, 29-35, 58, 60-63, 89-91; 93 * para [0119]; [0224]; pg. 21, Table 1 * | [A] HE ET AL.: "Recent Development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 469, 2014, pages 168 - 178, XP029029889, DOI: 10.1016/j.ijpharm.2014.04.056 [A] 1-8, 12-20, 29-35, 58, 60-63, 89-91; 93 * . pg. 172, Figure 4 A * DOI: http://dx.doi.org/10.1016/j.ijpharm.2014.04.056 |